Back to results
RecruitingPhase 3

A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

NCT05851014

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The First Affiliated Hospital of Bengbu Medical College

Bengbu, Anhui, China

+51 additional locations

Contact

Yankun Fu, Master

021-60751991yankun.fu@genorbio.com
View on ClinicalTrials.gov
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer — TrialFind